Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Canadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.
Journal: Current oncology (Toronto, Ont.)
Published: June 06, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: December 17, 2025
Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.
Journal: Current oncology (Toronto, Ont.)
Published: October 02, 2025
Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2025
Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.
Journal: Current oncology (Toronto, Ont.)
Published: July 30, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.
Journal: Annals of hematology
Published: July 14, 2025
Practical Guidance for the Expanded Implementation and Provision of Bispecific Antibodies for Diffuse Large B-Cell Lymphoma (DLBCL) Across Canada.
Journal: Current oncology (Toronto, Ont.)
Published: July 02, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.
Journal: British journal of haematology
Published: June 07, 2025
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study.
Journal: Leukemia & lymphoma
Published: August 12, 2024
Determining the best premedication regimen to prevent rabbit anti-human thymocyte globulin infusion-associated reactions: A retrospective study comparing two hematopoietic stem cell transplant centers.
Journal: Transplant immunology
Published: July 10, 2024
Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119].
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 09, 2024
Last Updated: 09/26/2026